In our study, serum levels of Ang-2 were a stronger predictor of survival than serum levels of VEGF-A, the principal angiogenic factor associated with poor outcome in colorectal cancer (Cao et al, 2009). The gene discussed is VEGFA; the disease is colorectal cancer.